Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2004

View Archived Issues

Synta Pharmaceuticals gives update on clinical status of its products

Cambridge Antibody Technology and Lonza extend manufacturing agreement

Sicor stockholders approve merger

Azelaic acid found more effective than metronidazole in moderate papulopustular rosacea

Analgesic effects of gabapentin in patients with chronic daily headache

Novel EP4 agonists with potential utility in female infertility, asthma, etc.

Lilly presents new GLP-1 analogues in a recent patent

New TPO mimetics in early development at GSK

Two novel series of NF-kappaB activation inhibitors patented by GSK

Tanabe Seiyaku scientists claim new inhibitors of alpha4 integrin-mediated cell adhesion

Takeda scientists describe new GRK2 inhibitors for heart failure therapy

New CGRP antagonists identified by BMS researchers

SPP-301 shows good tolerability and pharmacokinetics in healthy subjects

CR-4: a novel tyrosine kinase inhibitor active against ALL and AML cell lines

Samaritan Pharmaceuticals reports drug development update

CPMP recommends use of Ambirix in children

FR-210575: a candidate for the treatment of stroke and other neurodegenerative disorders

CPMP recommends extension of Paxene indications

European approval recommended for Lysodren

EntreMed identifies peptide fragment of tissue factor pathway inhibitor

Successful pre-IND meeting for Itax leads to phase III studies

Velcade recommended for approval in Europe

FDA extends review of anidulafungin NDA

Syrrx reports DP4 atomic structure, selects DP4 inhibitor candidates

RegeneRx licenses out European rights to TB4

Kowa and Nikken enter olmesartan medoxmil copromotion agreement

Evra available in Canada

Lundbeck and Pharmexa enter option agreement

Profile Therapeutics makes good progress during last six months of 2003

Diabetic endothelial dysfunction in ZDF rats normalized with chronic AVE-7688 treatment

Inex and Enzon partner to develop Onco TCS

Axonyx acquires interest in Oxis International

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...